Clinical trials
Enrolling by invitation Neurodegenerative Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Texas at Austin | 2 |
| BlueRock Therapeutics | 1 |
| Duke University | 1 |
| MapLight Therapeutics | 1 |
| Mayo Clinic | 1 |
| University of California, San Francisco | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
| Wake Forest University Health Sciences | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 10 |
| Nervous System Diseases | 5 |
| Alzheimer Disease | 4 |
| Parkinson Disease | 4 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Dementia | 3 |
| Aphasia, Primary Progressive | 2 |
| Cognitive Dysfunction | 2 |
| Frontotemporal Dementia | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.